GlassScriptPhysician profile
Todd A Bell
NPI 1659320711
$709.08
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $196 · 2021: $131 · 2022: $239.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $275.94 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $155.96 | 2022 | |
| Pfizer INC. | $106.25 | 2019-2020 | |
| Horizon Therapeutics Plc | $68.52 | 2020-2022 | |
| Convatec INC. | $24.03 | 2022 | |
| Grt US Holding, INC. | $22.59 | 2022 | |
| Kci USA, INC. | $22.18 | 2020 | |
| Alfasigma USA, INC. | $20.48 | 2021 | |
| Promius Pharma LLC | $13.13 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.